Publications by authors named "Steven N Chatfield"

Claim this Profile
T
The novel oral typhoid vaccine M01ZH09 is well tolerated and highly immunogenic in 2 vaccine presentations.
Beth D Kirkpatrick, Katherine M Tenney, Catherine J Larsson, J Patrick O'Neill, Cassandra Ventrone, Steven N Chatfield

J Infect Dis· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of Salmonella enterica serovar typhi DeltaaroC DeltassaV derivatives as vehicles for delivering heterologous antigens by chromosomal integration and in vivo inducible promoters.
Richard Stratford, Nicola D McKelvie, Nicky J Hughes, Emma Aldred, Claire Wiseman, Steven N Chatfield

Infect Immun· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of heterologous antigens in Salmonella Typhimurium vaccine vectors using the in vivo-inducible, SPI-2 promoter, ssaG.
Nicola D McKelvie, Richard Stratford, Tao Wu, Trevor Bellaby, Emma Aldred, Steven N Chatfield

Vaccine· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salmonella typhi and S typhimurium derivatives harbouring deletions in aromatic biosynthesis and Salmonella Pathogenicity Island-2 (SPI-2) genes as vaccines and vectors.
Shahid A Khan, Richard Stratford, Tao Wu, Nicola Mckelvie, Trevor Bellaby, Steven N Chatfield

Vaccine· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers.
Zoë Hindle, Steven N Chatfield, Jo Phillimore, Matthew Bentley, Julie Johnson

Infect Immun· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis